Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive genome-wide association study into multiple recurrence and progression risk in non-muscle invasive bladder cancer.

Cancer genetics - 1 Sept 2026

Hof Jasper P, Galesloot Tessel E, Aben Katja K H, Bryan Richard T, Catto James W F, Cheng Kar K, Conroy Samantha, Fleshner Neil E, van der Heijden Antoine G, James Nicholas D, Mengual Lourdes, Uunk Florine M, Verhaegh Gerald, Vrieling Alina, Zeegers Maurice P, Kiemeney Lambertus A L M, Vermeulen Sita H

Abstract excerpt

BACKGROUND: Patients with non-muscle invasive bladder cancer (NMIBC) frequently experience recurrence and may progress to muscle-invasive disease. Although several common germline variants associated with bladder cancer risk have been identified, their prognostic value in NMIBC remains unclear. We performed an updated genome-wide association study (GWAS), incorporating additional cohorts and analysing multiple...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Neoplasm Recurrence, Local

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 42320430
DOI: 10.1016/j.cancergen.2026.06.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive genome-wide association study into multiple recurrence and progression risk in non-muscle invasive bladder cancer.PMID 42320430Read ↗

Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non–muscle-invasive Bladder CancerSemantic proximity Read ↗

The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer in a genome-wide association study.Semantic proximity Read ↗

Novel Gene expression-based Risk Stratification tool predicts recurrence in Non-muscle invasive Bladder cancerSemantic proximity Read ↗

Prognostic relevance of urinary bladder cancer susceptibility loci.Semantic proximity Read ↗

Independent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment ResponseSemantic proximity Read ↗

The Roles of miRNAs in Predicting Bladder Cancer Recurrence and Resistance to TreatmentSemantic proximity Read ↗

Identification of a nine‐gene panel as a prognostic indicator for recurrence with muscle‐invasive bladder cancerSemantic proximity Read ↗

Prognostic Factors of Non-Muscle Invasive Bladder Cancer: A Study Based on Next-generation SequencingSemantic proximity Read ↗

Single Cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathwaySemantic proximity Read ↗

Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer.Semantic proximity Read ↗

Genomic and Therapeutic Landscape of Non-muscle-invasive Bladder Cancer.Semantic proximity Read ↗

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.